Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"Primary Liver Cancer: Challenges and Perspectives" presents the recent progress in basic and clinical research in Primary Liver Cancer (PLC) in China and around the world. PLC patients in China make up more than 50% of the total patients worldwide. By contributing to the book, the leading experts in the field of liver cancer in China as well as in the US share with readers their new concepts, practices, and experiences from bench to bed, from population study to individual survey, from molecular search to clinical practice, and from early diagnosis to treatment. The book is intended for researchers in the fields of epidemiology, molecular genetics, cell biology, immunology of HCC and other cancers, and clinical oncology in primary liver cancer. Jianren Gu is a Professor of molecular oncology at the Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine and Academician of Chinese Academy of Engineering.

Carcinoma, Hepatocellular -- diagnosis. --- Liver -- Cancer -- Diagnosis. --- Liver -- Cancer -- Treatment. --- Liver -- Cancer. --- Medicine. --- Cancer research. --- Immunology. --- Oncology. --- Epidemiology. --- Medicine & Public Health. --- Cancer Research. --- Oncology  . --- Tumors --- Diseases --- Public health --- Immunobiology --- Life sciences --- Serology --- Cancer research --- Cancer --- Research.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Hepatocellular Carcinoma: Targeted Therapy provides a detailed repository of the latest information regarding HCC epidemiology, diagnosis, imaging, pathology, staging, and treatment options. This volume also provides an up-to-date guide for treatment that explores not only traditional treatments, but newer investigational treatment options including surgical resection, liver transplantation, ablation (radiofrequency, microwave), percutaneous ethanol or acetic acid injection, transarterial chemoembolization (TACE), intra-arterial radiation therapy, and systemic chemotherapy. Heptocellular Carcinoma: Targeted Therapy will be of great value to all health care professionals and trainees worldwide who have an interest in the diagnosis and treatment of HCC, including surgeons, medical oncologists, radiologists, radiation oncologists, and pathologists.

Carcinoma, Hepatocellular -- Diagnosis. --- Carcinoma, Hepatocellular -- therapy. --- Liver -- Cancer -- Diagnosis. --- Liver -- Cancer -- Treatment. --- Liver -- Cancer. --- Liver Neoplasms. --- Liver Neoplasms --- Adenocarcinoma --- Carcinoma --- Digestive System Neoplasms --- Liver Diseases --- Neoplasms by Site --- Neoplasms, Glandular and Epithelial --- Digestive System Diseases --- Diseases --- Neoplasms by Histologic Type --- Neoplasms --- Carcinoma, Hepatocellular --- Medicine --- Surgery & Anesthesiology --- Education --- Health & Biological Sciences --- Social Sciences --- Oncology --- Surgery - General and By Type --- Education, Special Topics --- Liver --- Cancer --- Oncologic surgery --- Oncological surgery --- Surgical oncology --- Treatment. --- Surgery. --- Chemotherapy. --- Excision --- Medicine. --- Interventional radiology. --- Gastroenterology. --- Oncology. --- Pathology. --- Surgical oncology. --- Medicine & Public Health. --- Surgical Oncology. --- Interventional Radiology. --- Treatment